Albuterol Sulfate Solution
Product Images NDC 59651-183

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 59651-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 % Change From Pre-dose Fev1 Intent-to-treat Population Day 1 (Albuterol Fig1)

A line graph titled 'Figure 1 % Change from Pre-Dose FEV1 Intent-to-Treat Population Day 1,' depicting percent change over six hours from pre-dose. The graph compares albuterol sulfate solution inhalation treatments of 1.25 mg and 0.63 mg against placebo, showing three distinct trend lines with percent change on the vertical axis and hours post-dose on the horizontal axis.*

FDA Label Image

Figure 2 % Change From Pre-dose Fev1 Intent-to-treat Population Day 28 (Albuterol Fig2)

Line graph titled 'Figure 2' shows percent change from pre-dose FEV1 in an intent-to-treat population at Day 28. The x-axis represents hours from pre-dose (0 to 6 hours) and the y-axis shows percent change (0 to 30%). Three treatments are compared: albuterol 1.25 mg, albuterol 0.63 mg, and placebo. Both albuterol doses show a peak improvement around 0.5 to 1 hour post-dose with declines toward 6 hours, while placebo remains near baseline with minimal change.*

FDA Label Image

Figure 1 (Albuterol Fig3)

Illustration showing the use of a dropper to add liquid solution from a bottle into a small device with a mouthpiece, representing preparation of an inhalation solution dose for respiratory use.*

FDA Label Image

Figure 2 (Albuterol Fig4)

An instructional illustration showing a hand holding a respiratory inhalation device and another hand inserting a small cotton swab or similar applicator into the mouthpiece of the inhaler. The figure is labeled as Figure 2, likely part of usage or maintenance instructions for ALBUTEROL SULFATE inhalation solution.*

FDA Label Image

Figure 3, 4 (Albuterol Fig5)

An instructional illustration showing two figures demonstrating the use of a respiratory inhalation device. Figure 3 depicts a person inhaling through a mouthpiece attached to the device. Figure 4 shows a person inhaling through a face mask attached to the same device.*

FDA Label Image

Package Label-principal Display Panel (0.63 mg per 3 mL)

Albuterol Sulfate Inhalation Solution 0.63 mg per 3 mL vial label by Aurobindo Pharma Limited. The label states each 3 mL vial contains 0.75 mg albuterol sulfate equivalent, with unit-dose vials packaged in a pouch of five. It includes storage instructions, prescription-only use, and distribution details including the manufacturer address in East Windsor, NJ, and indicates the product is made in India.*

FDA Label Image

Package Label-principal Display Panel (0.63 mg per 3 mL – Container-Carton (25 Vials))

Packaging label for Albuterol Sulfate Inhalation Solution 0.63 mg per 3 mL, a sterile unit-dose solution for inhalation. The carton indicates potency expressed as albuterol, equivalent to 0.75 mg albuterol sulfate. The label shows it is distributed by Aurobindo Pharma USA, Inc. and contains 5 pouches of five 3 mL vials each. Storage and usage instructions are also included on the label.*

FDA Label Image

Package Label-principal Display Panel – 1.25 mg Per 3 mL (Pouch Label (5 Vials))

Label for Albuterol Sulfate Inhalation Solution 1.25 mg per 3 mL by Aurobindo Pharma Limited. The label indicates the product contains five sterile unit-dose vials of 3 mL each for inhalation use. It lists active and inactive ingredients, storage conditions, and usage instructions, along with the NDC 59651-184-05 and distribution details from Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (1.25 mg per 3 mL – Container-Carton (25 Vials))

Carton label for Albuterol Sulfate Inhalation Solution 1.25 mg per 3 mL sterile unit-dose vials. The label states potency expressed as albuterol equivalent to 1.5 mg albuterol sulfate. It includes usage instructions for inhalation only, storage conditions, inactive ingredients, and pharmacist dispensing information. Distributed by Aurobindo Pharma USA, Inc., the carton contains 5 pouches of five 3 mL vials each.*

FDA Label Image

Albuterol-str (Albuterol Str)

Chemical structure of albuterol sulfate, showing the molecular arrangement including the aromatic ring, hydroxyl groups, and the sulfate component represented as H2SO4.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.